Protalix BioTherapeutics, Inc. Share Price TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
TEL AVIV STOCK EXCHANGE
08:54:48 21/03/2023 pm IST
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| Market Cap | 22Cr 0 20Cr 19Cr 17Cr 32Cr 2.13TCr 32Cr 221.99Cr 85Cr 1.09TCr 84Cr 82Cr 3.49TCr | P/E 2026 * |
11.5x | P/E 2027 * | 55.2x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 0 20Cr 19Cr 17Cr 32Cr 2.13TCr 32Cr 221.99Cr 85Cr 1.09TCr 84Cr 82Cr 3.49TCr | EV / Sales 2026 * |
2.71x | EV / Sales 2027 * | 3.35x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 22Cr | |
| -2.33% | +0.53% | +51.65% | +115.42% | 1,03100Cr | |
| -1.06% | -1.65% | +42.78% | +69.98% | 64TCr | |
| -0.65% | -1.32% | +12.98% | +75.49% | 46TCr | |
| -2.66% | -1.87% | +73.13% | +41.15% | 36TCr | |
| -1.26% | -4.98% | +22.32% | +39.21% | 33TCr | |
| -1.69% | -0.27% | +14.05% | +27.06% | 27TCr | |
| -1.93% | -2.68% | -2.96% | +10.21% | 25TCr | |
| -0.50% | +3.80% | +49.37% | +56.84% | 23TCr | |
| -1.47% | -1.53% | +34.28% | +98.89% | 18TCr | |
| Average | -1.04% | -0.36% | +33.07% | +59.36% | 41.82TCr | |
| Weighted average by Cap. | -1.23% | -0.35% | +37.44% | +71.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.22Cr 0 7.23Cr 6.85Cr 6.19Cr 12Cr 787.76Cr 12Cr 82Cr 32Cr 402.72Cr 31Cr 30Cr 1.29TCr | 6.65Cr 0 5.85Cr 5.55Cr 5.01Cr 9.44Cr 637.43Cr 9.56Cr 66Cr 26Cr 325.87Cr 25Cr 24Cr 1.04TCr |
| Net income | 1.96Cr 0 1.73Cr 1.64Cr 1.48Cr 2.79Cr 188.24Cr 2.82Cr 20Cr 7.54Cr 96Cr 7.37Cr 7.21Cr 308.52Cr | 37.94L 0 33.41L 31.65L 28.58L 53.86L 36Cr 54.56L 3.79Cr 1.46Cr 19Cr 1.42Cr 1.39Cr 60Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
